KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Net Income (2018 - 2025)

ClearPoint Neuro's Net Income history spans 13 years, with the latest figure at -$5.9 million for Q3 2025.

  • For Q3 2025, Net Income fell 18.41% year-over-year to -$5.9 million; the TTM value through Sep 2025 reached -$23.4 million, down 28.34%, while the annual FY2024 figure was -$19.7 million, 12.03% up from the prior year.
  • Net Income for Q3 2025 was -$5.9 million at ClearPoint Neuro, down from -$5.8 million in the prior quarter.
  • Across five years, Net Income topped out at -$2.5 million in Q1 2021 and bottomed at -$7.1 million in Q2 2023.
  • The 5-year median for Net Income is -$4.5 million (2022), against an average of -$4.8 million.
  • The largest annual shift saw Net Income tumbled 174.36% in 2021 before it skyrocketed 38.2% in 2024.
  • A 5-year view of Net Income shows it stood at -$4.1 million in 2021, then fell by 7.82% to -$4.5 million in 2022, then decreased by 5.3% to -$4.7 million in 2023, then decreased by 20.02% to -$5.6 million in 2024, then fell by 4.3% to -$5.9 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Net Income are -$5.9 million (Q3 2025), -$5.8 million (Q2 2025), and -$6.0 million (Q1 2025).